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Letters to the Editordifference in gestational age (eg, 78 vs 83
days for 21 weeks’ human gestation) can
lead to a difference of 180 g for a singleton
fetus (720 vs 900 g). These weight differ-
ences can have substantial implications in
surgical technique. At the latter part of the
range (29 weeks’ human gestation), when
the fetus is growing more rapidly, the dif-
ference is even larger; for a 107-day (2.23
kg) versus 112-day (2.71 kg) singleton fe-
tus, the difference is about 500 g. Finally,
calculations based on these variations can
also greatly influence results. For example,
calculation of satisfactory fetal CPB flow
rates (on the basis of milliliters per kilo-
gram per hour) can be substantially differ-
ent and potentially inadequate when using
the wrong gestational age and fetal weight.
Joseph A. Sedgwick, MD
Pirooz Eghtesady, MD, PhD
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Reply to the Editor:
We appreciate the comments of Drs Sedg-
wick and Eghtesady.
Indeed, the increase in uteroplacental
blood flow during the course of pregnancy
initially reflects placental development and
thereafter vasodilation of the spiral arteries,
which increases perfusion of the intravil-
lous space. The increase in uterine blood
flow after 110 days in sheep (75% of the
236 The Journal of Thoracic and Cardiovagestation), which is associated with a
3-fold increase in fetal weight, is related to
vasodilation of the spiral arteries and has
been shown to be proportionate to the in-
crease in wet weight of the uterus and its
metabolically active tissues, including the
fetus, the membranes, and the placenta.1
When performing experiments, investi-
gators should always try to choose experi-
mental settings that are the closest to the
human model that they are trying to repro-
duce, bearing in mind, however, that no
model will ever correspond exactly to the
human condition. This is particularly true
when the experimental setting involves
pregnancies, which depend on a wide num-
ber of factors, including genetic, hormonal,
and anatomic factors, both on the maternal
and fetal side. As such, we welcome the
formula proposed by Drs Sedgwick and
Eghtesady but would caution against a
rigid application.
Uterine blood flow, for example, has
probably little effect in fetal cardiac bypass
experiments because the pump provides
perfusion only to the fetoplacental unit and
not to the maternal uteroplacental compart-
ment. Therefore, endometrial-myometrial
blood flow changes beyond 110 days of
pregnancy are not likely to significantly
influence fetal cardiac bypass.
The increase in fetoplacental blood flow
during the last third of pregnancy reflects
primarily vascular growth and, to a lesser
extent, vasodilation. This generates a fairly
stable fetal umbilical blood flow by the end
of pregnancy of approximately 200 mL ·
kg1 · min1 in most studied species. On
the other hand, placental weight during
ovine pregnancy is relatively stable after
the middle third of gestation.2 Taken to-
gether, these observations indicate that the
increase in fetoplacental blood flow during
the last third of the gestation is proportion-
ate to the increase of the fetal weight.
Therefore, planning of the pump perfusion
rate on the basis of the fetal weight as
predicted by fetal biometry3 at 300 mL ·
kg1 · min1 (100 mL · kg1 · min1 fetal
perfusion rate  200 mL · kg1 · min1
placental perfusion rate) is likely to be ap-
propriate during both the middle and the
last third of the pregnancy.
Beyond all these considerations, our
choice of using near-term fetal sheep orig-
inated primarily from the general consen-
sus in the literature of using animals at this
stage of pregnancy, which also allows us to
scular Surgery ● January 2005perform operations on larger fetuses. The
suggestion of lowering the gestational age
of future fetal experiments at 83 to 112
days of pregnancy in sheep is well ac-
cepted, but its benefits will need to be
proved experimentally.
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Separate or composite graft
replacement for diseases of both the
aortic valve and the ascending aorta
To the Editor:
With great interest, we read an excellent
article entitled “Clinical outcomes after
separate and composite replacement of the
aortic valve and ascending aorta,” in the
August 2004 issue of the Journal.1 Sioris
and associates reported the differences be-
tween aortic root replacement and aortic
valve replacement combined with supra-
coronary replacement of the ascending
aorta (separate grafting). They concluded
that separate grafting and the Bentall oper-
ation provide comparable long-term results
and that no patient required reoperation for
aortic root aneurysm after separate grafting
in patients with aortic valve disease asso-
ciated with normal or mildly dilated aortic
sinuses or a dilated ascending aorta. Their
study consisted of a large number of
patients (587 patients), and their mean
follow-up was 4.6  3.1 years.
We have a patient who required aortic
root replacement because of dilatation of
the residual sinuses of Valsalva 10 years
after separate grafting.2 The patient had
undergone the initial operation for type A
Letters to the Editoracute aortic dissection with severe aortic
regurgitation. Retrospectively, our patient
showed no dilatation of the sinuses of Val-
salva until 4 years after the operation. The
study by Sioris and associates1 included
some patients with aortic dissection or aor-
tic annulus ectasia. And no patient required
reoperation for aortic root aneurysm after
separate grafting in their follow-ups. As
they mentioned, separate grafting might be
a perfectly acceptable option for patients
with aortic valve disease and a dilated as-
cending aorta. However, we believe a care-
ful follow-up is imperative for patients un-
dergoing separate grafting because of the
possible risk involving dilation of the si-
nuses of Valsalva, particularly in patients
with evidence of gross annuloaortic ectasia
or cystic medionecrosis of the aortic wall.
Therefore we are looking forward to an
additional long-term report by Sioris and
associates.1
Yoshio Misawa, MD
Shin-ichi Ohki, MD
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Reply to the Editor:
Drs Misawa, Ohki, and Sakano expressed
concerns about our selective approach of
aortic valve replacement and supracoro-
nary replacement of the ascending aorta in
patients with aortic valve disease, a normal
aortic root, and a dilated ascending aorta,
as described in our recent article published
in the Journal.1 To emphasize their view-
point, they described a patient who under-
went surgical intervention for type A aortic
dissection with severe aortic insufficiency
and 10 years later required aortic root re-
placement because of aneurysm of the re-
tained aortic sinuses. I am not surprised
that their patient experienced this late com-
plication. Their patient had type A aortic
dissection with severe aortic insufficiency,
which suggests that the aortic sinuses were
involved by the dissection. I believe that
the appropriate operation for that patient
would have been an aortic valve-sparing
procedure, preferably the reimplantation
technique, or aortic root replacement to
remove the diseased aortic sinuses.
In our series1 only 5 of 44 patients with
type A aortic dissection had aortic valve
replacement and supracoronary replace-
ment of the ascending aorta, and none of
he Journal of Thoracic and Cardiovascularthe 5 patients had dissection of the aortic
sinuses or an aortic root aneurysm. The
remaining 39 patients with type A aortic
dissection had aortic root replacement, as
shown in Table 1 of our article. In addition,
no patient with Marfan syndrome or annu-
loaortic ectasia had supracoronary replace-
ment of the ascending aorta, as shown in
Table 1.
Aortic valve replacement with supra-
coronary replacement of the ascending
aorta is a valid and safe operation for pa-
tients with aortic cusp disease, normal aor-
tic sinuses, and dilation of the ascending
aorta. Although the series described in-
cluded patients operated on from 1990 on-
ward, and the longest follow-up is 14 years,
I have performed this operation during the
past 25 years and have never seen late
aortic root aneurysm. This means that I
have correctly tailored the operation to the
surgical pathology.
Tirone E. David, MD
Department of Surgery
University of Toronto
200 Elizabeth St
Toronto, Ontario M5G 2C4, Canada
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